Fat clues in diabetic pregnancies could predict baby size
NCT ID NCT00639964
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 186 pregnant women with type 1 or type 2 diabetes to understand how fats in the blood relate to baby birth weight. Researchers measured blood fats, diet, and placenta genes. The goal is to find new ways to prevent babies from being born too large, which can cause complications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify new ways to predict and prevent large birth weight in babies of mothers with diabetes.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct changes in care, and results may not apply to all pregnant women with diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
186 people
The number who actually took part.
- Start date
-
Jan 2008
- Finished
-
Dec 2013
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * pregnant women included before 16 amenorrhea weeks Exclusion Criteria: * obesity (BMI \> 40kg/m2) * subject became pregnant with medical infertility treatment * tobacco \> 10 * suspected abuse of alcohol
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pregnancy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU, Lille
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy aims to free type 1 diabetics from insulin shots
- Can Home-Delivered meals help control diabetes?
- Muscle-Injected gene therapy aims to help type 1 diabetes control blood sugar
- New pill takes aim at stubborn blood sugar
- Gene therapy shots aim to save legs from amputation in diabetes
- New pill takes aim at blood sugar in diabetes